Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Dr Stuart Quin, CEO of Medica Group PLC
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Dr Stuart Quin, CEO of Medica Group PLC, discusses the Group's first-half performance
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
PT MNC Asia Holding Tbk (BHIT) reports a net profit of Rp15.66 trillion in 2023, with the media sector as the primary contributor.
00:10:00
Greg Lang Highlights Nova Gold's Donlin Project: A Major High-Grade Gold Asset with Strong Partnerships and Permitting Progress
00:10:00
Tristram Leach serves as the Co-Head of European Credit at Apollo Global Management LLC.|Mr. Rowan is a Co-Founder and CEO of Apollo Global Management, Inc
00:10:00
Our dedication to the highest level of service goes beyond wealth|David Basner,CEO,TAG ASSOCIATES
00:10:00
focused on helping companies accelerate their trajectory by taking them straight to Series A as quickly as possible|Anamitra Banerji,Managing Partner,Afore Capital
00:10:00
Brooklyn Brock's Mission: Empowering Advisors for Intentional Living and Successful Exits | Brooklyn Brock, Founder, Ellevate Advisors LLC.
00:10:00
Insights on Capital Structure and Opportunities in the Commercial Real Estate Market
00:10:00
Quona invests in innovative fintech companies|Ganesh Rengaswamy,Managing Partner,Quona Capital
00:10:00
Our history with Chemring Energetic Devices | Michael Ord, Group Chief Executive, CHEMRING GROUP 7% PRFBC88:LSE
00:10:00
Thomas Peterffy, Chairman of Interactive Brokers, discusses the company's quarterly earnings on "Closing Bell Overtime."
00:10:00
Eric Kaufmann on Ethnic Shifts and Populism|Eric Kaufmann,Professor,University of London
00:10:00
Robert Ogór on AMBRA SA's 2020/2021 Financial Year and Future Directions | Robert Ogór, President, AMBRA SA.